中文版English

R&D



Keywords

- Enzalutamide intermediates

- Pharmaceutical intermediates

- Advanced anti-tumor intermediates


With the continuous advancement of targeted-therapy technologies, market demand for prostate-cancer targeted drugs keeps rising. Enzalutamide, a classic androgen receptor inhibitor, is widely used in clinical treatment. High-quality intermediates are the core foundation that ensures the synthetic quality of enzalutamide-class drugs.

Haohong Pharma focuses on the R&D and custom manufacturing of intermediates for innovative and generic drugs. Its Enzalutamide-series advanced intermediates are among the company's flagship strengths.

The synthesis of pharmaceutical intermediates is complex, involving many reaction steps, and is subject to extremely stringent industry standards for synthetic routes, reaction temperatures, purification processes, and impurity control. Even trace-level impurities above specification can directly affect the filing and clinical use of downstream products. Haohong Pharma has built a complete synthesis-development and quality-control system. From incoming raw-material screening, stepwise synthesis, and multi-stage purification and crystallization, to final drying, inspection, and packaging, every process is followed end-to-end by dedicated synthesis and analytical personnel. The company selects high-purity starting materials, continuously optimizes reaction processes to improve yield, and strictly controls related substances, heavy metals, moisture, and other parameters. Products show strong inter-batch consistency, with impurity levels stable and controllable.

Located in the Qihe High-tech Zone of Shandong Province — adjacent to Jinan — the company enjoys clear locational advantages and convenient logistics. The site houses an independent R&D laboratory, an analytical testing center, and a standardized pilot plant, equipped with precision instruments such as HPLC, GC, and mass spectrometers. Every batch ships with a complete COA (Certificate of Analysis), enabling full-process quality traceability. Backed by years of drug-synthesis experience, the R&D team flexibly adapts synthesis plans to the project needs of CROs and pharmaceutical companies, undertaking services across all stages — from lab-scale development and process optimization to pilot-scale scale-up and commercial production.

Beyond Enzalutamide intermediates, Haohong Pharma also develops intermediates for the same series of anti-tumor targeted drugs, such as Apalutamide, providing confidential custom-synthesis services to domestic pharmaceutical companies and R&D institutions. We adhere to compliant R&D and production, and with stable quality, controllable lead times, and professional technical support, we continuously supply reliable intermediate support to the upstream of the innovative anti-tumor drug value chain — helping targeted-therapy projects advance smoothly toward filing.

Haohong (Qihe) Pharmaceutical Technology Co., Ltd  Copyright (c) 2021 network support 

Tel:+86-0534-2153007 +86-0534-2152677   

Address: Block B, building 3, accelerator, high tech Zone, Qihe County, De Zhou City, Shandong Province

Domestic trade:sale@inyelchem.com